U.S. market Closed. Opens in 16 hours 11 minutes

EW | Edwards Lifesciences Corporation Stock Overview

(Stock Exchange: NYSE)
Day's Range 84.91 - 88.56
52 Week Range 60.57 - 96.12
Beta 1.09
Implied Volatility 35.71%
IV Rank 64.82%
Day's Volume 3,074,024
Average Volume 2,850,410
Shares Outstanding 602,600,000
Market Cap 51,709,106,000
Sector Healthcare
Industry Medical - Devices
IPO Date 2000-03-27
Valuation
Profitability
Growth
Health
P/E Ratio 36.99
Forward P/E Ratio 47.62
EPS 2.32
1YR Price Target 131.50
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 19,800
Country USA
Website EW
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. Its key products include surgical tissue heart valves, transcatheter valve technologies, surgical clips, catheters, and monitoring systems used to measure a patient's heart function during surgery.
EW's peers: ALGN, BSX, DXCM, MDT, ABT, ZBH, SYK, PODD, TNDM, INMD, MASS, NNOX, PHG, SENS
*Chart delayed
Analyzing fundamentals for EW we got that it has average fundamentals where Valuation is considered to be overvalued, Profitability is very wealthy, Growth is good and Health is confidently strong. For more detailed analysis please see EW Fundamentals page.

Watching at EW technicals we can see that long-term trend is bullish, while middle-term trend is bearish, as well as bearish short-term trend. More technicals details can be found on EW Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙